Ocrevus Zunovo Interactions
There are 507 drugs known to interact with Ocrevus Zunovo (hyaluronidase/ocrelizumab), along with 4 disease interactions. Of the total drug interactions, 44 are major, 386 are moderate, and 77 are minor.
- View all 507 medications that may interact with Ocrevus Zunovo
- View Ocrevus Zunovo disease interactions (4)
Most frequently checked interactions
View interaction reports for Ocrevus Zunovo (hyaluronidase / ocrelizumab) and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adzynma (apadamtase alfa, recombinant)
- Aimovig (erenumab)
- albuterol
- albuterol / ipratropium
- alendronate
- Alyftrek (deutivacaftor / tezacaftor / vanzacaftor)
- ambrisentan
- amitriptyline
- amlodipine
- Amondys 45 (casimersen)
- Amvuttra (vutrisiran)
- apple cider vinegar
- apremilast
- Aspirin Low Strength (aspirin)
- Attruby (acoramidis)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- Austedo XR (deutetrabenazine)
- azelastine nasal
- Azo Urinary Pain Relief (phenazopyridine)
- baclofen
- Bafiertam (monomethyl fumarate)
- Benadryl (diphenhydramine)
- Benlysta (belimumab)
- Eliquis (apixaban)
- Ocrevus (ocrelizumab)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Ocrevus Zunovo disease interactions
There are 4 disease interactions with Ocrevus Zunovo (hyaluronidase / ocrelizumab) which include:
Report options
More about Ocrevus Zunovo (hyaluronidase / ocrelizumab)
- Ocrevus Zunovo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: CD20 monoclonal antibodies
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Ocrevus
Ocrevus (ocrelizumab) is used for MS to treat relapsing and primary progressive forms of multiple ...
Tecfidera
Tecfidera (dimethyl fumarate) is used to treat relapsing forms of multiple sclerosis. Learn about ...
Avonex
Avonex is an interferon used to treat relapsing multiple sclerosis. It is given by injection into a ...
Briumvi
Briumvi is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Betaseron
Betaseron is used to treat relapsing multiple sclerosis (MS). Learn about side effects ...
Rebif
Rebif is used to treat relapsing forms of multiple sclerosis (MS) in adults, including clinically ...
Extavia
Extavia is used to treat the relapsing forms of multiple sclerosis. Learn about side effects ...
Kesimpta
Kesimpta (ofatumumab) is used to treat relapsing forms of multiple sclerosis. Includes Kesimpta ...
Copaxone
Copaxone is used to treat relapsing forms of multiple sclerosis (MS) in adults (including ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
